Evidence map›Paper›PMID 33138354›Full record

ArticleAccounts of chemical research2020

Maxamycins: Durable Antibiotics Derived by Rational Redesign of Vancomycin.

Zhi-Chen Wu, Dale L Boger

Open access · greenAbstract read
In one paragraph

Article in Accounts of chemical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Supernatural Products.The Chemist · 2025
    Article
  6. Article
  7. Fighting Antimicrobial Resistance: Innovative Drugs in Antibacterial Research.Angewandte Chemie (International ed. in English) · 2025
    Review
  8. Strategic re-engineering of antibiotics.Nature reviews bioengineering · 2025
    Article
  9. Polyanionic Receptors for Carboxylates in Water.Angewandte Chemie (International ed. in English) · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Divergent Total Synthesis and Characterization of Maxamycins.Journal of the American Chemical Society · 2023
    Article
  17. Article
  18. Review
  19. Natural products and drug discovery.National science review · 2022
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Zhi-Chen WuDepartment of Chemistry and Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.
Dale L BogerDepartment of Chemistry and Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, California 92037, United States.ORCID 0000-0002-3966-3317
Scripps Research Institute · US

Funding

LUZOPEPTINS, VANCOMYCIN AND RELATED AGENTSR01CA041101 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L · 1985 to 2024
$9.5M
NCI NIH HHS R01 CA041101
6 · The paper itself

Abstract

Since its discovery, vancomycin has been used in the clinic for >60 years. Because of their durability, vancomycin and related glycopeptides serve as the antibiotics of last resort for the treatment of protracted bacterial infections of resistant Gram-positive pathogens, including methicillin-resistant

Indexed as

Drug DesignAnti-Bacterial AgentsBinding SitesDipeptidesGlycopeptidesGuanidineHalf-LifeMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsStaphylococcus aureusVancomycinVancomycin ResistancealanylalanineAnti-Bacterial AgentsDipeptidesGlycopeptidesGuanidineVancomycin

Identifiers

PMID33138354
PMCPMC7674238
OpenAlexW3095889889

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.